Global Personalized Medicines Market Research Report 2025(Status and Outlook)

March 2025 | 171 pages | ID: GB2244B5A842EN
Bosson Research

Abstracts

Report Overview

Personalized medicine is tailoring of a treatment to a specific patient i.e. designing medicine treatment on the basis of diagnosis, disease condition, patient history, body physics, and other factors related to patients and diseases. Personalized medicine is also known as precision medicine, stratified medicine, or P4 medicine.

This report provides a deep insight into the global Personalized Medicines market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Personalized Medicines Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Personalized Medicines market in any manner.

Global Personalized Medicines Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

3G Biotech

Quest Diagnostics

Laboratory Corporation of America

Abbott

Agendia NV

Asuragen Inc

Becton Dickinson

CardioDx Inc.

Foundation Medicine

Qiagen

Siemens Healthcare

Amgen

Bristol-Myers Squibb

GE Healthcare

Pfizer

Sanofi

23andMe

Illumina

Market Segmentation (by Type)

PM Diagnostics

PM Therapeutics

Personalized Medical Care

Personalized Nutrition & Wellness

Market Segmentation (by Application)

Hospitals Pharmacies

Retail Pharmacies

Dietary Care Centers

Others

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Personalized Medicines Market
• Overview of the regional outlook of the Personalized Medicines Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Personalized Medicines Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Personalized Medicines
1.2 Key Market Segments
  1.2.1 Personalized Medicines Segment by Type
  1.2.2 Personalized Medicines Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 GLOBAL PERSONALIZED MEDICINES MARKET OVERVIEW

2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 GLOBAL PERSONALIZED MEDICINES MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Personalized Medicines Product Life Cycle
3.3 Global Personalized Medicines Revenue Market Share by Company (2020-2025)
3.4 Personalized Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Personalized Medicines Company Headquarters, Area Served, Product Type
3.6 Personalized Medicines Market Competitive Situation and Trends
  3.6.1 Personalized Medicines Market Concentration Rate
  3.6.2 Global 5 and 10 Largest Personalized Medicines Players Market Share by Revenue
  3.6.3 Mergers & Acquisitions, Expansion

4 DEVELOPMENT AND DYNAMICS OF PERSONALIZED MEDICINES MARKET

4.1 Key Development Trends
4.2 Driving Factors
4.3 Market Challenges
4.4 Market Restraints
4.5 Industry News
  4.5.1 New Product Developments
  4.5.2 Mergers & Acquisitions
  4.5.3 Expansions
  4.5.4 Collaboration/Supply Contracts
4.6 PEST Analysis
  4.6.1 Industry Policies Analysis
  4.6.2 Economic Environment Analysis
  4.6.3 Social Environment Analysis
  4.6.4 Technological Environment Analysis
4.7 Global Personalized Medicines Market Porter's Five Forces Analysis

5 GLOBAL PERSONALIZED MEDICINES MARKET SEGMENTATION BY REGION

5.1 Global Personalized Medicines Market Size by Region
5.2 Global Personalized Medicines Market Size by Country

6 NORTH AMERICA MARKET OVERVIEW

6.1 North America Personalized Medicines Market Size by Country
  6.1.1 USA Market Overview
  6.1.2 Canada Market Overview
  6.1.3 Mexico Market Overview
6.2 North America Personalized Medicines Market Size by Type
6.3 North America Personalized Medicines Market Size by Application

7 EUROPE MARKET OVERVIEW

7.1 Europe Personalized Medicines Market Size by Country
  7.1.1 Germany Market Overview
  7.1.2 France Market Overview
  7.1.3 U.K. Market Overview
  7.1.4 Italy Market Overview
  7.1.5 Spain Market Overview
7.2 Europe Personalized Medicines Market Size by Type
7.3 Europe Personalized Medicines Market Size by Application

8 ASIA-PACIFIC MARKET OVERVIEW

8.1 Asia-Pacific Personalized Medicines Market Size by Country
  8.1.1 China Market Overview
  8.1.2 Japan Market Overview
  8.1.3 South Korea Market Overview
  8.1.4 India Market Overview
  8.1.5 Southeast Asia Market Overview
8.2 Asia-Pacific Personalized Medicines Market Size by Type
8.3 Asia-Pacific Personalized Medicines Market Size by Application

9 SOUTH AMERICA MARKET OVERVIEW

9.1 South America Personalized Medicines Market Size by Country
  9.1.1 Brazil Market Overview
  9.1.2 Argentina Market Overview
  9.1.3 Columbia Market Overview
9.2 South America Personalized Medicines Market Size by Type
9.3 South America Personalized Medicines Market Size by Application

10 MIDDLE EAST AND AFRICA MARKET OVERVIEW

10.1 Middle East and Africa Personalized Medicines Market Size by Country
  10.1.1 Saudi Arabia Market Overview
  10.1.2 UAE Market Overview
  10.1.3 Egypt Market Overview
  10.1.4 Nigeria Market Overview
  10.1.5 South Africa Market Overview
10.2 Middle East and Africa Personalized Medicines Market Size by Type
10.3 Middle East and Africa Personalized Medicines Market Size by Application

11 PERSONALIZED MEDICINES MARKET SEGMENTATION BY TYPE

11.1 Evaluation Matrix of Segment Market Development Potential (Type)
11.2 Global Personalized Medicines Market Share by Type (2020-2033)
11.3 Global Personalized Medicines Growth Rate by Type (2020-2033)

12 PERSONALIZED MEDICINES MARKET SEGMENTATION BY APPLICATION

12.1 Evaluation Matrix of Segment Market Development Potential (Application)
12.2 Global Personalized Medicines Market Size (M USD) by Application (2020-2033)
12.3 Global Personalized Medicines Growth Rate by Application (2020-2033)

13 KEY COMPANIES PROFILE

13.1 3G Biotech
  13.1.1 3G Biotech Basic Information
  13.1.2 3G Biotech Personalized Medicines Product Overview
  13.1.3 3G Biotech Personalized Medicines Product Market Performance
  13.1.4 3G Biotech Personalized Medicines SWOT Analysis
  13.1.5 3G Biotech Business Overview
  13.1.6 3G Biotech Recent Developments
13.2 Quest Diagnostics
  13.2.1 Quest Diagnostics Basic Information
  13.2.2 Quest Diagnostics Personalized Medicines Product Overview
  13.2.3 Quest Diagnostics Personalized Medicines Product Market Performance
  13.2.4 Quest Diagnostics Personalized Medicines SWOT Analysis
  13.2.5 Quest Diagnostics Business Overview
  13.2.6 Quest Diagnostics Recent Developments
13.3 Laboratory Corporation of America
  13.3.1 Laboratory Corporation of America Basic Information
  13.3.2 Laboratory Corporation of America Personalized Medicines Product Overview
  13.3.3 Laboratory Corporation of America Personalized Medicines Product Market Performance
  13.3.4 Laboratory Corporation of America Personalized Medicines SWOT Analysis
  13.3.5 Laboratory Corporation of America Business Overview
  13.3.6 Laboratory Corporation of America Recent Developments
13.4 Abbott
  13.4.1 Abbott Basic Information
  13.4.2 Abbott Personalized Medicines Product Overview
  13.4.3 Abbott Personalized Medicines Product Market Performance
  13.4.4 Abbott Business Overview
  13.4.5 Abbott Recent Developments
13.5 Agendia NV
  13.5.1 Agendia NV Basic Information
  13.5.2 Agendia NV Personalized Medicines Product Overview
  13.5.3 Agendia NV Personalized Medicines Product Market Performance
  13.5.4 Agendia NV Business Overview
  13.5.5 Agendia NV Recent Developments
13.6 Asuragen Inc
  13.6.1 Asuragen Inc Basic Information
  13.6.2 Asuragen Inc Personalized Medicines Product Overview
  13.6.3 Asuragen Inc Personalized Medicines Product Market Performance
  13.6.4 Asuragen Inc Business Overview
  13.6.5 Asuragen Inc Recent Developments
13.7 Becton Dickinson
  13.7.1 Becton Dickinson Basic Information
  13.7.2 Becton Dickinson Personalized Medicines Product Overview
  13.7.3 Becton Dickinson Personalized Medicines Product Market Performance
  13.7.4 Becton Dickinson Business Overview
  13.7.5 Becton Dickinson Recent Developments
13.8 CardioDx Inc.
  13.8.1 CardioDx Inc. Basic Information
  13.8.2 CardioDx Inc. Personalized Medicines Product Overview
  13.8.3 CardioDx Inc. Personalized Medicines Product Market Performance
  13.8.4 CardioDx Inc. Business Overview
  13.8.5 CardioDx Inc. Recent Developments
13.9 Foundation Medicine
  13.9.1 Foundation Medicine Basic Information
  13.9.2 Foundation Medicine Personalized Medicines Product Overview
  13.9.3 Foundation Medicine Personalized Medicines Product Market Performance
  13.9.4 Foundation Medicine Business Overview
  13.9.5 Foundation Medicine Recent Developments
13.10 Qiagen
  13.10.1 Qiagen Basic Information
  13.10.2 Qiagen Personalized Medicines Product Overview
  13.10.3 Qiagen Personalized Medicines Product Market Performance
  13.10.4 Qiagen Business Overview
  13.10.5 Qiagen Recent Developments
13.11 Siemens Healthcare
  13.11.1 Siemens Healthcare Basic Information
  13.11.2 Siemens Healthcare Personalized Medicines Product Overview
  13.11.3 Siemens Healthcare Personalized Medicines Product Market Performance
  13.11.4 Siemens Healthcare Business Overview
  13.11.5 Siemens Healthcare Recent Developments
13.12 Amgen
  13.12.1 Amgen Basic Information
  13.12.2 Amgen Personalized Medicines Product Overview
  13.12.3 Amgen Personalized Medicines Product Market Performance
  13.12.4 Amgen Business Overview
  13.12.5 Amgen Recent Developments
13.13 Bristol-Myers Squibb
  13.13.1 Bristol-Myers Squibb Basic Information
  13.13.2 Bristol-Myers Squibb Personalized Medicines Product Overview
  13.13.3 Bristol-Myers Squibb Personalized Medicines Product Market Performance
  13.13.4 Bristol-Myers Squibb Business Overview
  13.13.5 Bristol-Myers Squibb Recent Developments
13.14 GE Healthcare
  13.14.1 GE Healthcare Basic Information
  13.14.2 GE Healthcare Personalized Medicines Product Overview
  13.14.3 GE Healthcare Personalized Medicines Product Market Performance
  13.14.4 GE Healthcare Business Overview
  13.14.5 GE Healthcare Recent Developments
13.15 Pfizer
  13.15.1 Pfizer Basic Information
  13.15.2 Pfizer Personalized Medicines Product Overview
  13.15.3 Pfizer Personalized Medicines Product Market Performance
  13.15.4 Pfizer Business Overview
  13.15.5 Pfizer Recent Developments
13.16 Sanofi
  13.16.1 Sanofi Basic Information
  13.16.2 Sanofi Personalized Medicines Product Overview
  13.16.3 Sanofi Personalized Medicines Product Market Performance
  13.16.4 Sanofi Business Overview
  13.16.5 Sanofi Recent Developments
13.17 23andMe
  13.17.1 23andMe Basic Information
  13.17.2 23andMe Personalized Medicines Product Overview
  13.17.3 23andMe Personalized Medicines Product Market Performance
  13.17.4 23andMe Business Overview
  13.17.5 23andMe Recent Developments
13.18 Illumina
  13.18.1 Illumina Basic Information
  13.18.2 Illumina Personalized Medicines Product Overview
  13.18.3 Illumina Personalized Medicines Product Market Performance
  13.18.4 Illumina Business Overview
  13.18.5 Illumina Recent Developments

14 CONCLUSION AND KEY FINDINGS
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Personalized Medicines Market Size by Type (M USD)
Table 4. Global Personalized Medicines Market Size by Application (M USD)
Table 5. Personalized Medicines Market Size Comparison by Region (M USD)
Table 6. Global Personalized Medicines Revenue (M USD) by Company (2020-2025)
Table 7. Global Personalized Medicines Revenue Share by Company (2020-2025)
Table 8. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Medicines as of 2024)
Table 9. Personalized Medicines Company Headquarters and Area Served
Table 10. Company Personalized Medicines Product Type
Table 11. Global Personalized Medicines Company Market Concentration Ratio (CR5 and HHI)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Key Development Trends
Table 14. Driving Factors
Table 15. Personalized Medicines Market Challenges
Table 16. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 17. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 18. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 19. Personalized Medicines Market Size Comparison by Region (M USD)
Table 20. Global Personalized Medicines Market Size by Region (2020-2033) & (M USD)
Table 21. Global Personalized Medicines Market Share by Region (2020-2025)
Table 22. North America Personalized Medicines Market Size by Country (2020-2033) & (M USD)
Table 23. North America Personalized Medicines Market Size by Type (M USD)
Table 24. North America Personalized Medicines Market Size (M USD) by Type (2020-2033)
Table 25. North America Personalized Medicines Market Size by Application (M USD)
Table 26. North America Personalized Medicines Market Size (M USD) by Application (2020-2033)
Table 27. Europe Personalized Medicines Market Size by Country (2020-2033) & (M USD)
Table 28. Europe Personalized Medicines Market Size by Type (M USD)
Table 29. Europe Personalized Medicines Market Size (M USD) by Type (2020-2033)
Table 30. Europe Personalized Medicines Market Size by Application (M USD)
Table 31. Europe Personalized Medicines Market Size (M USD) by Application (2020-2033)
Table 32. Asia-Pacific Personalized Medicines Market Size by Country (2020-2025) & (M USD)
Table 33. Asia-Pacific Personalized Medicines Market Size by Type (M USD)
Table 34. Asia-Pacific Personalized Medicines Market Size (M USD) by Type (2020-2025)
Table 35. Asia-Pacific Personalized Medicines Market Size by Application (M USD)
Table 36. Asia-Pacific Personalized Medicines Market Size (M USD) by Application (2020-2025)
Table 37. South America Personalized Medicines Market Size by Country (2020-2033) & (M USD)
Table 38. South America Personalized Medicines Market Size by Type (M USD)
Table 39. South America Personalized Medicines Market Size (M USD) by Type (2020-2033)
Table 40. South America Personalized Medicines Market Size by Application (M USD)
Table 41. South America Personalized Medicines Market Size (M USD) by Application (2020-2033)
Table 42. Middle East and Africa Personalized Medicines Market Size by Country (2020-2033) & (M USD)
Table 43. Middle East and Africa Personalized Medicines Market Size by Type (M USD)
Table 44. Middle East and Africa Personalized Medicines Market Size (M USD) by Type (2020-2033)
Table 45. Middle East and Africa Personalized Medicines Market Size by Application (M USD)
Table 46. Middle East and Africa Personalized Medicines Market Size (M USD) by Application (2020-2033)
Table 47. Global Personalized Medicines Market Size by Type (M USD)
Table 48. Global Personalized Medicines Market Size (M USD) by Type (2020-2033)
Table 49. Global Personalized Medicines Market Share by Type (2020-2033)
Table 50. Global Personalized Medicines Market Size by Application(M USD)
Table 51. Global Personalized Medicines Market Size by Application (2020-2033) & (M USD)
Table 52. Global Personalized Medicines Market Share by Application (2020-2033)
Table 53. Global Personalized Medicines Growth Rate by Application (2020-2033)
Table 54. 3G Biotech Basic Information
Table 55. 3G Biotech Personalized Medicines Product Overview
Table 56. 3G Biotech Personalized Medicines Revenue (M USD) and Gross Margin (2020-2025)
Table 57. 3G Biotech Personalized Medicines SWOT Analysis
Table 58. 3G Biotech Business Overview
Table 59. 3G Biotech Recent Developments
Table 60. Quest Diagnostics Basic Information
Table 61. Quest Diagnostics Personalized Medicines Product Overview
Table 62. Quest Diagnostics Personalized Medicines Revenue (M USD) and Gross Margin (2020-2025)
Table 63. Quest Diagnostics Personalized Medicines SWOT Analysis
Table 64. Quest Diagnostics Business Overview
Table 65. Quest Diagnostics Recent Developments
Table 66. Laboratory Corporation of America Basic Information
Table 67. Laboratory Corporation of America Personalized Medicines Product Overview
Table 68. Laboratory Corporation of America Personalized Medicines Revenue (M USD) and Gross Margin (2020-2025)
Table 69. Laboratory Corporation of America Personalized Medicines SWOT Analysis
Table 70. Laboratory Corporation of America Business Overview
Table 71. Laboratory Corporation of America Recent Developments
Table 72. Abbott Basic Information
Table 73. Abbott Personalized Medicines Product Overview
Table 74. Abbott Personalized Medicines Revenue (M USD) and Gross Margin (2020-2025)
Table 75. Abbott Business Overview
Table 76. Abbott Recent Developments
Table 77. Agendia NV Basic Information
Table 78. Agendia NV Personalized Medicines Product Overview
Table 79. Agendia NV Personalized Medicines Revenue (M USD) and Gross Margin (2020-2025)
Table 80. Agendia NV Business Overview
Table 81. Agendia NV Recent Developments
Table 82. Asuragen Inc Basic Information
Table 83. Asuragen Inc Personalized Medicines Product Overview
Table 84. Asuragen Inc Personalized Medicines Revenue (M USD) and Gross Margin (2020-2025)
Table 85. Asuragen Inc Business Overview
Table 86. Asuragen Inc Recent Developments
Table 87. Becton Dickinson Basic Information
Table 88. Becton Dickinson Personalized Medicines Product Overview
Table 89. Becton Dickinson Personalized Medicines Revenue (M USD) and Gross Margin (2020-2025)
Table 90. Becton Dickinson Business Overview
Table 91. Becton Dickinson Recent Developments
Table 92. CardioDx Inc. Basic Information
Table 93. CardioDx Inc. Personalized Medicines Product Overview
Table 94. CardioDx Inc. Personalized Medicines Revenue (M USD) and Gross Margin (2020-2025)
Table 95. CardioDx Inc. Business Overview
Table 96. CardioDx Inc. Recent Developments
Table 97. Foundation Medicine Basic Information
Table 98. Foundation Medicine Personalized Medicines Product Overview
Table 99. Foundation Medicine Personalized Medicines Revenue (M USD) and Gross Margin (2020-2025)
Table 100. Foundation Medicine Business Overview
Table 101. Foundation Medicine Recent Developments
Table 102. Qiagen Basic Information
Table 103. Qiagen Personalized Medicines Product Overview
Table 104. Qiagen Personalized Medicines Revenue (M USD) and Gross Margin (2020-2025)
Table 105. Qiagen Business Overview
Table 106. Qiagen Recent Developments
Table 107. Siemens Healthcare Basic Information
Table 108. Siemens Healthcare Personalized Medicines Product Overview
Table 109. Siemens Healthcare Personalized Medicines Revenue (M USD) and Gross Margin (2020-2025)
Table 110. Siemens Healthcare Business Overview
Table 111. Siemens Healthcare Recent Developments
Table 112. Amgen Basic Information
Table 113. Amgen Personalized Medicines Product Overview
Table 114. Amgen Personalized Medicines Revenue (M USD) and Gross Margin (2020-2025)
Table 115. Amgen Business Overview
Table 116. Amgen Recent Developments
Table 117. Bristol-Myers Squibb Basic Information
Table 118. Bristol-Myers Squibb Personalized Medicines Product Overview
Table 119. Bristol-Myers Squibb Personalized Medicines Revenue (M USD) and Gross Margin (2020-2025)
Table 120. Bristol-Myers Squibb Business Overview
Table 121. Bristol-Myers Squibb Recent Developments
Table 122. GE Healthcare Basic Information
Table 123. GE Healthcare Personalized Medicines Product Overview
Table 124. GE Healthcare Personalized Medicines Revenue (M USD) and Gross Margin (2020-2025)
Table 125. GE Healthcare Business Overview
Table 126. GE Healthcare Recent Developments
Table 127. Pfizer Basic Information
Table 128. Pfizer Personalized Medicines Product Overview
Table 129. Pfizer Personalized Medicines Revenue (M USD) and Gross Margin (2020-2025)
Table 130. Pfizer Business Overview
Table 131. Pfizer Recent Developments
Table 132. Sanofi Basic Information
Table 133. Sanofi Personalized Medicines Product Overview
Table 134. Sanofi Personalized Medicines Revenue (M USD) and Gross Margin (2020-2025)
Table 135. Sanofi Business Overview
Table 136. Sanofi Recent Developments
Table 137. 23andMe Basic Information
Table 138. 23andMe Personalized Medicines Product Overview
Table 139. 23andMe Personalized Medicines Revenue (M USD) and Gross Margin (2020-2025)
Table 140. 23andMe Business Overview
Table 141. 23andMe Recent Developments
Table 142. Illumina Basic Information
Table 143. Illumina Personalized Medicines Product Overview
Table 144. Illumina Personalized Medicines Revenue (M USD) and Gross Margin (2020-2025)
Table 145. Illumina Business Overview
Table 146. Illumina Recent Developments
List of Figures
Figure 1. Industry Chain of Personalized Medicines
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Personalized Medicines Market Size (M USD), 2024-2033
Figure 5. Global Personalized Medicines Market Size (M USD) (2020-2033)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Personalized Medicines Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Personalized Medicines Product Life Cycle
Figure 12. Global Personalized Medicines Revenue Share by Company in 2024
Figure 13. Personalized Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 14. The Global 5 and 10 Largest Players: Market Share by Personalized Medicines Revenue in 2024
Figure 15. Global Personalized Medicines Market PESTE Analysis
Figure 16. Global Personalized Medicines Market Porter's Five Forces Analysis
Figure 17. Evaluation Matrix of Regional Market Development Potential
Figure 18. Global Personalized Medicines Market Size by Region
Figure 19. Global Personalized Medicines Market Size by Country (M USD)
Figure 20. North American Market Snapshot
Figure 21. North America Personalized Medicines Market Size and Growth Rate (2020-2033) & (M USD)
Figure 22. North America Personalized Medicines Market Size (M USD) by Country
Figure 23. USA Personalized Medicines Market Size and Growth Rate (2020-2033) & (M USD)
Figure 24. Canada Personalized Medicines Market Size (M USD) and Growth Rate (2020-2033)
Figure 25. Mexico Personalized Medicines Market Size (M USD) and Growth Rate (2020-2033)
Figure 26. North America Personalized Medicines Market Size (M USD) by Type
Figure 27. North America Personalized Medicines Market Size (M USD) by Application
Figure 28. Europe Market Snapshot
Figure 29. Europe Personalized Medicines Market Size and Growth Rate (2020-2033) & (M USD)
Figure 30. Europe Personalized Medicines Market Size (M USD) by Country
Figure 31. Germany Personalized Medicines Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. France Personalized Medicines Market Size and Growth Rate (2020-2033) & (M USD)
Figure 33. U.K. Personalized Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 34. Italy Personalized Medicines Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Spain Personalized Medicines Market Size and Growth Rate (2020-2033) & (M USD)
Figure 36. Europe Personalized Medicines Market Size (M USD) by Type
Figure 37. Europe Personalized Medicines Market Size (M USD) by Application
Figure 38. Asia-Pacific Market Snapshot
Figure 39. Asia-Pacific Personalized Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Asia-Pacific Personalized Medicines Market Size (M USD) by Country
Figure 41. China Personalized Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 42. Japan Personalized Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 43. South Korea Personalized Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. India Personalized Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. Southeast Asia Personalized Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. Asia-Pacific Personalized Medicines Market Size (M USD) by Type
Figure 47. Asia-Pacific Personalized Medicines Market Size (M USD) by Application
Figure 48. South America Market Snapshot
Figure 49. South America Personalized Medicines Market Size and Growth Rate (2020-2033) & (M USD)
Figure 50. South America Personalized Medicines Market Size (M USD) by Country
Figure 51. Brazil Personalized Medicines Market Size and Growth Rate (2020-2033) & (M USD)
Figure 52. Argentina Personalized Medicines Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Columbia Personalized Medicines Market Size and Growth Rate (2020-2033) & (M USD)
Figure 54. South America Personalized Medicines Market Size (M USD) by Type
Figure 55. South America Personalized Medicines Market Size (M USD) by Application
Figure 56. Middle East and Africa Market Snapshot
Figure 57. Middle East and Africa Personalized Medicines Market Size and Growth Rate (2020-2033) & (M USD)
Figure 58. Middle East and Africa Personalized Medicines Market Size (M USD) by Country
Figure 59. Saudi Arabia Personalized Medicines Market Size and Growth Rate (2020-2033) & (M USD)
Figure 60. UAE Personalized Medicines Market Size and Growth Rate (2020-2033) & (M USD)
Figure 61. Egypt Personalized Medicines Market Size and Growth Rate (2020-2033) & (M USD)
Figure 62. Nigeria Personalized Medicines Market Size and Growth Rate (2020-2033) & (M USD)
Figure 63. South Africa Personalized Medicines Market Size and Growth Rate (2020-2033) & (M USD)
Figure 64. Middle East and Africa Personalized Medicines Market Size (M USD) by Type
Figure 65. Middle East and Africa Personalized Medicines Market Size (M USD) by Application
Figure 66. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 67. Global Personalized Medicines Market Size by Type (M USD)
Figure 68. Market Share of Personalized Medicines by Type (2020-2033)
Figure 69. Market Share of Personalized Medicines by Type in 2024
Figure 70. Global Personalized Medicines Growth Rate by Type (2020-2033)
Figure 71. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 72. Global Personalized Medicines Market Size by Application (M USD)
Figure 73. Global Personalized Medicines Market Share by Application
Figure 74. Global Personalized Medicines Market Share by Application (2020-2033)
Figure 75. Global Personalized Medicines Market Share by Application in 2024
Figure 76. Global Personalized Medicines Growth Rate by Application (2020-2033)